Sphere Fluidics in European Biopharmaceutical Review July 2021

 

Featured Article in European Biopharmaceutical Review July 2021

 

Fully integrated and automated picodroplet systems continue to push the boundaries of biologic discovery by accelerating research, expanding the scope of exploration, and reducing upstream development costs. These technologies are extensively used in antibody discovery and cell line development, providing a high throughput and sensitive method for performing quantitative screening assays, and the applications are expanding.

Emerging applications of picodroplet technology in biopharmaceutical discovery includes bispecific antibody (bsAb) development, cell line engineering, and cell therapy research, which are explored in this article.

This article is taken from European Biopharmaceutical Review July 2021, pages 18-20. © Samedan Ltd